Abstract
Orally administered [51Cr]EDTA was used to measure intestinal permeability in subjects with infectious diarrhea and in those without gastrointestinal complaints. [51Cr]EDTA was given to 87 subjects: 63 controls (32 normal controls, and 31 disease controls), and 24 patients with infectious diarrhea. Approximately 100 μCi of [51Cr]EDTA was given orally after an overnight fast. Urine was collected for the following 24 hr. Intestinal permeability to [51Cr]EDTA in both normal volunteers and in patients with a variety of diseases not associated with intestinal injury was low and results were in a relatively narrow range. Mean 24-hr urinary excretion of [51Cr]EDTA, calculated as a percent of the administered dose, in controls was 1.6% (0.2–3.5%). Patients with infectious diarrhea associated with invasive pathogens and/or intestinal inflammation had increased excretion of [51Cr]EDTA (mean 6.1%,P<0.0001), with elevated excretions in 75%. These results demonstrate that intestinal infections must be considered as possible causes for increased intestinal permeability as assessed by the [51Cr]EDTA test.
Similar content being viewed by others
References
Bjarnason I, Peters TJ, Levi AJ: Intestinal permeability: Clinical correlates. Dig Dis 4:83–92, 1986
Bjarnason I, Peters TJ, Veall N: A persistent defect in intestinal permeability in coeliac disease demonstrated by a51Cr-labeled EDTA absorption test. Lancet 1:323–325, 1983
Chadwick VS, Phillips SF, Hofmann AF: Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 73:247–251, 1977
Menzies IS, Pounder R, Heyer S, Laker MF, Bull J, Wheeler PG, Creamer B: Abnormal intestinal permeability to sugars in villous atrophy. Lancet 2:1107–1109, 1979
Menzies IS: Transmucosal passage of inert molecules in health and disease.In Intestinal Absorption and Secretion (Falk Symposium 36). E Skadhauge, K Heintz (eds). Lancaster; MTP Press, 1984, Chap 45, pp 527–543
Anonymous: Intestinal permeability. Lancet 1:256–258, 1985
Casellas F, Aguade S, Soriano B, Accarino A, Molero J, Guarner L: Intestinal permeability to99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease. Am J Gastroenterol 81:767–770, 1986
Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI: Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 105:883–885, 1986
Maxton DG, Bjarnason I, Reynolds AP, Catt SD, Peters TJ, Menzies IS: Lactulose,51Cr-labeled ethylenediaminetetraacetate,l-rhamnose and polyethyleneglycol 500 as probe markers for assessmentin vivo of human intestinal permeability. Clin Sci 71:71–80, 1986
Elia M, Behrens R, Northrop C, Wraight P, Neale G: Evaluation of mannitol, lactulose and51Cr-labeled ethylenediaminetetra-acetate as markers of intestinal permeability in man. Clin Sci 73:197–204, 1987
Resnick RH, Royal H, Marshall W, Barron R, Werth T: Intestinal permeability in gastrointestinal disease. Use of oral [99mTc]DTPA. Dig Dis Sci 35:205–211, 1990
Rask-Madsen J, Schwartz M: Absorption of51Cr-EDTA in ulcerative colitis following rectal instillation. Scand J Gastroenterol 5:361–368, 1970
Jenkins AP, Trew DR, Crump BJ, Nukajam WS, Foley JA, Menzies IS, Creamer B: Do non-steroidal anti-inflammatory drugs increase colonic permeability? Gut 32:66–69, 1991
Jenkins RT, Ramage JK, Jones DB, Collins SM, Goodacre RL, Hunt RH: Small bowel and colonic permeability to51Cr-EDTA in patients with active inflammatory bowel disease. Clin Invest Med 11:151–155, 1988
O'Morain CA, Abelow AC, Chervu LR, Fleischner GM, Das KM: Chromium 51-ethylenediaminetetracetate test: A useful test in the assessment of inflammatory bowel disease. J Lab Clin Med 108:430–435, 1986
Bjarnason I, O'Morain C, Levi AJ, Peters TJ: Absorption of 51-chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology 85:318–322, 1983
Bjarnason I, Ward K, Peters TJ: The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1:179–182, 1984
Bjarnason I, Williams P, So A, Zanelli GD, Levi AJ, Gumpel JM, Peters TJ, Ansell B: Intestinal permeability and inflammation in rheumatoid arthritis: Effects of non-steroidal antiinflammatory drugs. Lancet 2:1171–1174, 1984
Bjarnason I, Marsh MN, Price A, Levi AJ, Peters TJ: Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis. Gut 26:1214–1219, 1985
Forget P, Sodoyez-Goffaux F, Zappitelli A: Permeability of the small intestine to51Cr-EDTA in children with acute gastroenteritis or eczema. J Pediatr Gastroenterol Nutr 4:393–396, 1985
Peled Y, Watz C, Gilat T: Measurement of intestinal permeability using51Cr-EDTA. Am J Gastroenterol 80:770–773, 1985
Hetzel PAS, LaBrooy JT, Bellon M, Davidson GP, Johnson RB, Chatterton BE, Shearman DJC: The51Cr-EDTA absorption test in coeliac patients treated with a gluten free diet. IRCS J Med Sci 14:1183–1184, 1986
Jenkins RT, Jones DB, Goodacre RL, Collins SM, Coates G, Hund RH, Bienenstock J: Reversibility of increased intestinal permeability to51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol 11:1159–1164, 1987
Bourke S, Murphy B, Stafford F, Maher K, O'Morain C: Population differences in intestinal permeability to chromium EDTA. Irish J Med Sci 157:287–289, 1988
Aabakken L:51Cr-Ethylenediaminetetraacetic acid absorption test. Methodologic aspects. Scand J Gastroenterol 24:351–358, 1989
Ainsworth M, Eriksen J, Rasmussen JW, Schaffalitzky de Muckadell OB: Intestinal permeability of51Cr-labeled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scand J Gastroenterol 24:993–998, 1989
Prytz H, Benoni C, Tagesson C: Does smoking tighten the gut? Scand J Gastroenterol 24:1084–1088, 1989
Pironi L, Miglioli M, Ruggeri E, Levorato M, Dallasta MA, Corbelli C, Nibali MG, Barbara L: Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease. Dig Dis Sci 35:582–588, 1990
Schrander JJP, Unsalan-Hooyen RWM, Forget PP, Jansen J: [51Cr]EDTA intestinal permeability in children with cow's milk intolerance. J Pediatr Gastroenterol Nutr 10:189–192, 1990
Mielants H, Goemaere S, De Vos M, Schelstraete K, Goethals K, Maertens M, Ackerman C, Veys EM: Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs. J Rheumatol 18:389–393, 1991
O'Mahony CP, Stevens FM, Bourke M, McCarthy CF, Weir DG, Feighery CF:51Cr-EDTA test for coeliac disease. Lancet 1:1354–1355, 1984 (letter)
Turck D, Ythier H, Maquet E, Deveaux M, Marchandise X, Farriaux JP, Fontaine G: Intestinal permeability to [51Cr]EDTA in children with Crohn's disease and celiac disease. J Pediatr Gastroenterol Nutr 6:535–537, 1987
Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ: Effect of nonsteroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 27:1292–1297, 1986
Jenkins RT, Rooney PJ, Jones DB, Bienenstock J, Goodacre RL: Increased intestinal permeability in patients with rheumatoid arthritis: A side-effect of oral nonsteroidal antiinflammatory drug therapy. Br J Rheumatol 26:103–107, 1987
Aabakken L, Osnes M.51Cr-Ethylenediaminetetraacetic acid absorption test. Effects of naproxen, a non-steroidal, antiinflammatory drug. Scand J Gastroenterol 25:917–924, 1990
Bjarnason I, Levi S, Smethurst P, Menzies IS, Levi AJ: Vindaloo and you. Br Med J 297:24–31, 1988
Ford RPK, Menzies IS, Phillips AD, Walker-Smith JA, Turner MW: Intestinal sugar permeability: Relationship to diarrhoeal disease and small bowel morphology. J Pediatr Gastroenterol Nutr 4:568–574, 1985
Noone C, Menzies IS, Banatvala JE, Scopes JW: Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation. Eur J Clin Invest 16:217–225, 1986
Kordossis T, Joseph AEA, Gane JN, Bridges CE, Griffin GE: Fecal leukocytosis, indium-111-labeled autologous polymorphonuclear leukocyte abdominal scanning, and quantitative fecal indium-111 excretion in acute gastroenteritis and enteropathogen carriage. Dig Dis Sci 33:1383–1390, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zuckerman, M.J., Watts, M.T., Bhatt, B.D. et al. Intestinal permeability to [51Cr]EDTA in infectious diarrhea. Digest Dis Sci 38, 1651–1657 (1993). https://doi.org/10.1007/BF01303174
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01303174